Companion Animal Diagnostic Market Set For Rapid Growth, To Reach Value Around USD 7795.64 million by 2032
Zion Market Research has published a new report titled “Companion Animal Diagnostic Market by Companion Animal (Dogs, Cats, Equine, and Others) and by Technology (Immunodiagnostics [ELISA, Lateral Flow Assays, Immunoassay Analyzers, and Others], Clinical Biochemistry, Hematology, Molecular Diagnostics [PCR, Microarrays and Others], Urinalysis, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024—2032”.
According to the report, The global companion animal diagnostic market size was worth around USD 2702.88 million in 2023 and is predicted to grow to around USD 7795.64 million by 2032 with a compound annual growth rate (CAGR) of roughly 12.49% between 2024 and 2032.
Market Analysis: Companion Animal Diagnostic
Introduction:
Overview of companion animal diagnostics and their importance in veterinary medicine.Explanation of the increasing focus on preventive healthcare for pets.
Methodology:
Description of the methodology employed for market analysis.Sources utilized, including industry reports, market surveys, and expert interviews.
Global Market Size:
Total revenue generated by the global companion animal diagnostic market.Historical growth trends and forecasts for future market expansion.
Since the past decade, there has been a rising trend in pet adoption across the globe. The reputable animal healthcare companies are taking efforts in developing veterinary diagnostic and imaging systems that are cost-effective and efficient. As per the APP (American Pet Products Association), the number of pets owned in the U.S. households has increased by 2.1%, which is significantly higher than it was twenty years ago. Moreover, the rise in the number of nuclear families is triggering the increase in pet ownership. Thus, intensive animal farming and increased expenditure on pet care by owners, especially in advanced countries, are likely to positively impact the companion animal diagnostic market in the estimated time period.
The companion animal diagnostic market is segmented on the basis of companion animal and technology. By companion animal, the market is segmented into dogs, cats, equine, and others. Cats are likely to hold a large market share in the forecast time period. Around 80 million dogs and 85 million cats are owned alone in the U.S. and this number is likely to increase in the future. Urine screening is the most widely used diagnostic screening test to detect cat diseases. Dogs are expected to display a high growth rate in the upcoming period, owing to the availability of fast and affordable DNA tests to detect dog diseases.
By technology, the market is segmented into immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, urinalysis, and others. The immunodiagnostics is further segmented into ELISA, lateral flow assays, immunoassay analyzers, and others. The molecular diagnostics market is further segmented into PCR, microarrays, and others. Clinical biochemistry held a major share in the companion animal diagnostic market globally. Scientists and clinical vets use most of the therapeutic and diagnostic tools to treat diseases, the introduction of micro methods, and advanced veterinary care in clinical laboratories are propelling the clinical biochemistry segment. The molecular diagnostic is anticipated to register the highest CAGR in the forecast time period, owing to its major focus on pathogens detection, identification, and genotyping. Furthermore, it is also widely used in livestock and veterinary research for vaccine development, host-pathogen interactions, and micro biome.
By region, North America is anticipated to dominate the companion animal diagnostic market and hold a major market share in the forecast period. The presence of major industry players and initiatives taken by them toward animal care is likely to propel the region’s companion animal diagnostic market. The key market players are taking initiatives and collaborating with various animal welfare organizations to improve and create awareness for companion animal healthcare. For instance, Ceva, in 2015, renewed its partnership with American Association of Feline Practitioners, to protect animals against diseases further encouraging pet owners to live in urbanized societies and take better care of the pets further establishing standards for research, surgery practices and feline medicine and raising awareness among practitioners and owners.
Companion Animal Diagnostic Market: Competitive Analysis
The global companion animal diagnostic market is led by players like:
Thermo Fisher Scientific
Heska Corporation
QIAGEN
Randox Laboratories
Abaxis, Inc.
IDEXX Laboratories, Inc.
Neogen Corp.
Virbac
Zoetis Inc.
This report segments the global companion animal diagnostic market into:
Global Companion Animal Diagnostic Market: Companion Animal Analysis
Dogs
Cats
Equine
Others
Global Companion Animal Diagnostic Market: Technology Analysis
ImmunodiagnosticsELISALateral Flow AssaysImmunoassay AnalyzersOthers
Clinical Biochemistry
Hematology
Molecular DiagnosticsPCRMicroarraysOthers
Urinalysis
Others
Global Companion Animal Diagnostic Market: Regional Analysis
North AmericaThe U.S.
EuropeUKFranceGermany
Asia PacificChinaJapanIndia
Latin AmericaBrazil
The Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com
Comments
Post a Comment